$142 Million is the total value of EMORY UNIVERSITY's 45 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 28.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRKA | BERKSHIRE HATHAWAY INC DELcl a | $35,242,000 | -1.6% | 117 | 0.0% | 24.77% | -12.2% | |
| JD | Sell | JD COM INCspon adr cl a | $11,985,000 | +44.0% | 397,528 | -0.0% | 8.42% | +28.5% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $3,823,000 | +55.6% | 32,477 | -17.2% | 2.69% | +38.8% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $2,840,000 | +36.1% | 208,854 | -4.1% | 2.00% | +21.4% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $2,804,000 | +59.2% | 135,058 | +4.4% | 1.97% | +42.0% |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $2,796,000 | – | 156,401 | +100.0% | 1.96% | – |
| ZGNX | Sell | ZOGENIX INC | $2,792,000 | +32.4% | 50,758 | -12.2% | 1.96% | +18.1% |
| ACAD | Sell | ACADIA PHARMACEUTICALS INC | $2,754,000 | +38.9% | 102,586 | -16.3% | 1.94% | +23.9% |
| SLDB | Buy | SOLID BIOSCIENCES INC | $2,750,000 | +49.3% | 298,887 | +335.0% | 1.93% | +33.2% |
| IFRX | Sell | INFLARX NV | $2,716,000 | -8.3% | 71,884 | -11.7% | 1.91% | -18.2% |
| MYOV | Sell | MYOVANT SCIENCES LTD | $2,672,000 | +31.2% | 111,925 | -9.8% | 1.88% | +17.0% |
| RARX | Sell | RA PHARMACEUTICALS INC | $2,665,000 | -1.8% | 118,959 | -20.2% | 1.87% | -12.4% |
| RTRX | Buy | RETROPHIN INC | $2,503,000 | +19.0% | 110,627 | +19.0% | 1.76% | +6.2% |
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $2,492,000 | +38.0% | 28,287 | +11.9% | 1.75% | +23.1% |
| ALXN | Sell | ALEXION PHARMACEUTICALS INC | $2,491,000 | +30.1% | 18,429 | -6.3% | 1.75% | +16.0% |
| WVE | Buy | WAVE LIFE SCIENCES LTD | $2,464,000 | +0.7% | 63,434 | +8.9% | 1.73% | -10.2% |
| INCY | Sell | INCYTE CORP | $2,453,000 | +8.2% | 28,518 | -20.1% | 1.72% | -3.5% |
| SGEN | Sell | SEATTLE GENETICS INC | $2,444,000 | +3.8% | 33,368 | -19.7% | 1.72% | -7.4% |
| THOR | New | SYNTHORX INC | $2,439,000 | – | 119,735 | +100.0% | 1.71% | – |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $2,423,000 | -5.8% | 45,771 | -26.9% | 1.70% | -15.9% |
| BGNE | Sell | BEIGENE LTDsponsored adr | $2,381,000 | -6.6% | 18,039 | -0.7% | 1.67% | -16.7% |
| ARGX | New | ARGENX SEsponsored adr | $2,349,000 | – | 18,819 | +100.0% | 1.65% | – |
| ATNX | New | ATHENEX INC | $2,312,000 | – | 188,696 | +100.0% | 1.62% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $2,254,000 | +8.9% | 25,376 | +4.4% | 1.58% | -2.8% |
| MDGL | Buy | MADRIGAL PHARMACEUTICALS INC | $2,209,000 | +15.0% | 17,632 | +3.5% | 1.55% | +2.6% |
| CRNX | Buy | CRINETICS PHARMACEUTICALS IN | $2,209,000 | -14.3% | 97,035 | +12.9% | 1.55% | -23.5% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $2,196,000 | +0.2% | 230,892 | -6.8% | 1.54% | -10.7% |
| RYTM | Sell | RHYTHM PHARMACEUTICALS INC | $2,176,000 | -2.2% | 79,398 | -4.1% | 1.53% | -12.8% |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS | $2,157,000 | -15.9% | 265,013 | -16.6% | 1.52% | -25.0% |
| ARNA | New | ARENA PHARMACEUTICALS INC | $2,142,000 | – | 47,779 | +100.0% | 1.51% | – |
| HRTX | Buy | HERON THERAPEUTICS INC | $2,113,000 | -3.3% | 86,477 | +2.6% | 1.48% | -13.8% |
| STX | Sell | SEAGATE TECHNOLOGY PLC | $2,022,000 | +20.0% | 42,219 | -3.3% | 1.42% | +7.0% |
| GHDX | Sell | GENOMIC HEALTH INC | $2,005,000 | +2.7% | 28,619 | -5.6% | 1.41% | -8.4% |
| ADS | Buy | ALLIANCE DATA SYSTEMS CORP | $1,950,000 | +36.7% | 11,142 | +17.2% | 1.37% | +22.0% |
| MS | Buy | MORGAN STANLEY | $1,940,000 | +14.5% | 45,964 | +7.5% | 1.36% | +2.1% |
| KKR | Sell | KKR & CO INCcl a | $1,927,000 | +14.2% | 82,041 | -4.5% | 1.35% | +1.9% |
| CBRE | Sell | CBRE GROUP INCcl a | $1,907,000 | +9.4% | 38,566 | -11.4% | 1.34% | -2.4% |
| ACA | New | ARCOSA INC | $1,874,000 | – | 61,342 | +100.0% | 1.32% | – |
| BHC | Buy | BAUSCH HEALTH COS INC | $1,873,000 | +37.9% | 75,828 | +3.1% | 1.32% | +23.0% |
| C | Buy | CITIGROUP INC | $1,868,000 | +23.3% | 30,027 | +3.2% | 1.31% | +10.0% |
| SLM | Sell | SLM CORP | $1,685,000 | +13.2% | 170,029 | -5.1% | 1.18% | +0.9% |
| TRN | Sell | TRINITY INDS INC | $1,646,000 | -2.2% | 75,769 | -7.3% | 1.16% | -12.7% |
| SMLP | SUMMIT MIDSTREAM PARTNERS LP | $852,000 | -3.2% | 87,560 | 0.0% | 0.60% | -13.6% | |
| COCP | COCRYSTAL PHARMA INC | $417,000 | -24.2% | 152,916 | 0.0% | 0.29% | -32.3% | |
| SPY | Buy | SPDR S&P 500 ETF TRtr unit | $266,000 | +22.0% | 942 | +8.0% | 0.19% | +8.7% |
| AMZN | Exit | AMAZON COM INC | $0 | – | -158 | -100.0% | -0.19% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -149,013 | -100.0% | -1.11% | – |
| AWI | Exit | ARMSTRONG WORLD INDS INC NEW | $0 | – | -28,514 | -100.0% | -1.31% | – |
| IMMU | Exit | IMMUNOMEDICS INC | $0 | – | -123,101 | -100.0% | -1.38% | – |
| DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -172,524 | -100.0% | -1.45% | – |
| XLRN | Exit | ACCELERON PHARMA INC | $0 | – | -45,445 | -100.0% | -1.56% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -31,959 | -100.0% | -1.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TR | 23 | Q3 2020 | 71.4% |
| SEATTLE GENETICS INC | 22 | Q2 2019 | 3.7% |
| MORGAN STANLEY | 22 | Q2 2019 | 1.7% |
| VANGUARD INTL EQUITY INDEX F | 18 | Q3 2015 | 100.0% |
| BIOMARIN PHARMACEUTICAL INC | 18 | Q2 2019 | 3.3% |
| MICROSOFT CORP | 17 | Q1 2018 | 1.9% |
| CITIGROUP INC | 16 | Q2 2019 | 1.4% |
| GENOMIC HEALTH INC | 15 | Q3 2019 | 3.6% |
| EXPRESS SCRIPTS HLDG CO | 15 | Q1 2018 | 3.8% |
| ACADIA PHARMACEUTICALS INC | 14 | Q2 2019 | 3.8% |
View EMORY UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| GeoVax Labs, Inc. | March 29, 2018 | 4,621,405 | 3.5% |
| Geovax Labs, Inc. | October 10, 2006 | 233,905,253 | 33.0% |
View EMORY UNIVERSITY's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR/A | 2024-02-06 |
| 13F-HR | 2024-02-01 |
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-11 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-13 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-09 |
| 13F-HR | 2019-02-12 |
View EMORY UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.